Routine SEC filings from multiple biotechnology and healthcare companies

Six SEC regulatory filings were submitted July 23-24, 2026, by unrelated companies including Scribe Therapeutics, Artiva Biotherapeutics, Doximity, Gossamer Bio, and TCG Crossover GP II. The filings cover routine insider holdings disclosures (Forms 3 and 4) and amended beneficial/institutional ownership reports (Schedules 13D/A and 13G/A).

SEC regulatory filings from six unrelated companies July 24

Six public companies filed separate 8-K forms with the SEC on July 24, covering unrelated corporate matters from officer compensation to financial results. The cluster represents routine regulatory disclosures with no common narrative thread.

EFFECT - QUANTUM CORP /DE/ (0000709283) (Filer)

8-K - T1 Energy Inc. (0001992243) (Filer)